NovoCure
NVCR
NVCR
58 hedge funds and large institutions have $196M invested in NovoCure in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $249M → $196M (-$52.9M)
Holders
58
Holding in Top 10
2
Calls
$3.03M
Puts
$1.38M
Top Buyers
| 1 | +$26.3M | |
| 2 | +$5.04M | |
| 3 | +$3.69M | |
| 4 |
HCM
Highline Capital Management
New York
|
+$1.59M |
| 5 |
RCM
Riverhead Capital Management
Wilmington,
Delaware
|
+$673K |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$2.4M | |
| 3 | -$1.5M | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$807K |
| 5 |
Two Sigma Investments
New York
|
-$639K |